Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system

Authors

Michael A. Jarvis, School of Biomedical Sciences
Frederick A. Hansen, National Institutes of Health
Kyle Rosenke, National Institutes of Health
Elaine Haddock, National Institutes of Health
Christopher Rollinson, University Hospitals Plymouth NHS Trust
Simon Rule, University Hospitals Plymouth NHS Trust
Graham Sewell, School of Health Professions
Andrew Hughes, University of Manchester
Heinz Feldmann, National Institutes of Health

ORCID

• Michael A. Jarvis: 0000-0002-0124-4061

DOI

10.3851/imp3368

Publication Date

2020-08-03

Publication Title

Antiviral Therapy

ISSN

1359-6535

Embargo Period

2020-11-19

Recommended Citation

Jarvis, M., Hansen, F., Rosenke, K., Haddock, E., Rollinson, C., Rule, S., Sewell, G., Hughes, A., & Feldmann, H. (2020) 'Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system', Antiviral Therapy, . Available at: 10.3851/imp3368